Section 10 - Cystic Fibrosis Clinical Care Pathway
Section 10 - Cystic Fibrosis Clinical Care Pathway
Section 10 - Cystic Fibrosis Clinical Care Pathway
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Section</strong> Two:<br />
Pulmonary Management<br />
2.1 Physiotherapy<br />
Chest physiotherapy is an integral part of the management of CF. It is<br />
thought to prevent and reduce pulmonary complications such as atelectasis<br />
and hyperinflation by the removal of bronchopulmonary secretions. Removal<br />
of these secretions reduces the overall proteolytic activity in the lungs, which<br />
could reduce the progression of elastase-mediated damage to the airways and<br />
the mucociliary transport system. The role of the physiotherapist is not<br />
limited to airway clearance but also includes encouragement and advice on<br />
exercise, posture, mobility and inhalation therapy.<br />
Most patients with CF do require some form of chest physiotherapy daily,<br />
however this should be tailored to their individual needs, according to age,<br />
clinical status and social circumstances.<br />
2.1.1 Management of infants<br />
and small children<br />
Traditionally it has been recommended that newly diagnosed infants with CF<br />
begin a twice-daily regimen of postural drainage and percussion undertaken<br />
by a parent or guardian. Postural drainage is carried out in alternate side lying<br />
with a head down tip, supine, prone and in the sitting position. The rationale<br />
for this approach has been based on three arguments. Firstly, early<br />
intervention may prevent the onset of complications and secondly that there<br />
is clear evidence from studies of bronchoalveolar lavage, infant lung function<br />
and radiological imaging that manifestations of lung disease occur at a very<br />
early stage in the disease process. Lastly it is argued that introducing a routine<br />
of chest physiotherapy from an early stage so that it becomes part of the<br />
child’s daily routine will improve compliance with treatment.<br />
With earlier diagnosis and particularly the introduction of neonatal screening<br />
many infants now presenting with CF have very little in the way of<br />
respiratory symptoms and are often well nourished. Although daily treatment<br />
continues to be recommended even in this asymptomatic group of patients<br />
there is as yet no evidence to suggest that routine physiotherapy has an<br />
impact on the course of the pulmonary changes. Furthermore poor adherence<br />
to treatment has been associated with the lack of immediate and obvious<br />
benefit from therapies and daily regimens of chest physiotherapy place a<br />
significant burden on parents and carers. In preference to a routine<br />
17